| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Fibrogen Inc (KYNB) has 6 insiders with recent SEC Form 4 filings, including 0 buys and 34 sells. KYNB is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 60.0K | $412.8K | - | |
| CFO | 26.0K | $178.9K | - | |
| Dir | 7.0K | $48.2K | - | |
| Dir | 7.0K | $48.2K | - | |
| Dir | 7.0K | $48.2K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 20, 2018 | Neff Thomas B | Chief Executive Officer | Sale+OE | 39,636 | $57.81 | $2,291,197.54 | -0.3% | |
| Sep 17, 2018 | Kurkijarvi Kalevi | Director | Sale+OE | 4,000 | $58.86 | $235,456.00 | -7.6% | |
| Sep 13, 2018 | Cotroneo Pat | SVP, Finance And CFO | Sale+OE | 2,318 | $59.50 | $137,921.00 | -1.0% | |
| Sep 10, 2018 | Routti Jorma | Director | Sale+OE | 6,000 | $57.31 | $343,837.00 | -2.2% | |
| Sep 10, 2018 | Cotroneo Pat | SVP, Finance And CFO | Sell | 1,011 | $57.35 | $57,980.85 | -0.5% | |
| Sep 7, 2018 | Neff Thomas B | Chief Executive Officer | Sale+OE | 39,636 | $57.51 | $2,279,499.92 | -0.3% | |
| Aug 22, 2018 | Tamura Toshinari | Director | Sale+OE | 12,000 | $60.65 | $727,800.00 | -18.8% | |
| Aug 21, 2018 | Neff Thomas B | Chief Executive Officer | Sale+OE | 39,636 | $60.24 | $2,387,764.82 | -0.4% | |
| Aug 16, 2018 | Rosenkranz Roberto Pedro | Director | Sale+OE | 1,000 | $60.28 | $60,278.80 | -1.5% | |
| Aug 16, 2018 | Kurkijarvi Kalevi | Director | Sale+OE | 4,000 | $60.28 | $241,127.50 | -7.4% |